| Year |
Citation |
Score |
| 2020 |
Robb CM, Kour S, Contreras JI, Agarwal E, Barger CJ, Rana S, Sonawane Y, Neilsen BK, Taylor M, Kizhake S, Thakare RN, Chowdhury S, Wang J, Black JD, Hollingsworth MA, et al. Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 11: 2462-2463. PMID 32637035 DOI: 10.18632/Oncotarget.27403 |
0.711 |
|
| 2020 |
Rana S, Kour S, Sonawane YA, Robb CM, Contreras JI, Kizhake S, Zahid M, Karpf AR, Natarajan A. Symbiotic Prodrugs (SymProDs) Dual Targeting of NFkappaB and CDK. Chemical Biology & Drug Design. PMID 32237047 DOI: 10.1111/Cbdd.13684 |
0.752 |
|
| 2019 |
Kour S, Rana S, Contreras JI, King HM, Robb CM, Sonawane YA, Bendjennat M, Crawford AJ, Barger CJ, Kizhake S, Luo X, Hollingsworth MA, Natarajan A. CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax. Molecular Pharmacology. 96: 419-429. PMID 31467029 DOI: 10.1124/Mol.119.116855 |
0.725 |
|
| 2018 |
Contreras JI, Robb CM, King HM, Baxter J, Crawford AJ, Kour S, Kizhake S, Sonawane YA, Rana S, Hollingsworth MA, Luo X, Natarajan A. Chemical Genetic Screens Identify Kinase Inhibitor Combinations that Target Anti-Apoptotic Proteins for Cancer Therapy. Acs Chemical Biology. PMID 29608269 DOI: 10.1021/Acschembio.8B00077 |
0.717 |
|
| 2018 |
Robb CM, Kour S, Contreras JI, Agarwal E, Barger CJ, Rana S, Sonawane Y, Neilsen BK, Taylor M, Kizhake S, Thakare RN, Chowdhury S, Wang J, Black JD, Hollingsworth MA, et al. Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 9: 5216-5232. PMID 29435174 DOI: 10.18632/Oncotarget.23749 |
0.75 |
|
| 2017 |
Robb CM, Contreras JI, Kour S, Taylor MA, Abid M, Sonawane YA, Zahid M, Murry DJ, Natarajan A, Rana S. Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC). Chemical Communications (Cambridge, England). PMID 28636052 DOI: 10.1039/C7Cc03879H |
0.723 |
|
| 2017 |
Agarwal E, Robb CM, Smith LM, Brattain MG, Wang J, Black JD, Chowdhury S. Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis. Oncogene. PMID 28068324 DOI: 10.1038/Onc.2016.460 |
0.515 |
|
| 2015 |
Robb CM. Abstract 3088: Inhibition of CDK5 in colorectal cancer Cancer Research. 75: 3088-3088. DOI: 10.1158/1538-7445.Am2015-3088 |
0.581 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2014 |
Park H, Turkalo TK, Nelson K, Folmsbee SS, Robb C, Roper B, Azuma M. Ewing sarcoma EWS protein regulates midzone formation by recruiting Aurora B kinase to the midzone. Cell Cycle (Georgetown, Tex.). 13: 2391-9. PMID 25483190 DOI: 10.4161/cc.29337 |
0.283 |
|
| 2012 |
D'Incecco A, Landi L, Fountzilas G, Kalogeras KT, Geva R, Kako S, Robb CM, Frattini M, Rossi E, Salvini J, Ludovini V, Crinò L, Cappuzzo F, Varella-Garcia M. MYC gene copy number (GCN) and sensitivity to anti-EGFR monoclonal antibodies in metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 30: e21018-e21018. DOI: 10.1200/jco.2012.30.15_suppl.e21018 |
0.169 |
|
| 2024 |
Robb C, Rajput MZ, Raptis D, Bhalla S. Don't skip a beat! Critical findings in imaging studies performed in adults with congenital heart disease. Current Problems in Diagnostic Radiology. PMID 38272749 DOI: 10.1067/j.cpradiol.2024.01.005 |
0.12 |
|
| 2022 |
Raptis DA, Short R, Robb C, Marlow J, Naeem M, McWilliams S, White AJ, Chakinala M, Picus D, Bhalla S. CT Appearance of Pulmonary Arteriovenous Malformations and Mimics. Radiographics : a Review Publication of the Radiological Society of North America, Inc. 42: 56-68. PMID 34990315 DOI: 10.1148/rg.210076 |
0.026 |
|
| Hide low-probability matches. |